Literature DB >> 28624429

Squamous cell carcinoma of the retromolar trigone: Treatment outcomes.

Hideaki Nishi1, Takeshi Shinozaki2, Toshifumi Tomioka2, Takashi Maruo2, Ryuichi Hayashi2.   

Abstract

OBJECTIVE: Squamous cell carcinoma (SCC) of the retromolar trigone is uncommon, accounting for 1.4% of all oral cancer cases in Japan. Few studies have examined the optimal treatment for this cancer. The aim of this study was to evaluate the outcome of treatment for primary SCC of the retromolar area.
METHODS: We retrospectively analyzed the outcome and prognosis of 45 patients (38 men, 7 women) with SCC of the retromolar trigone who underwent treatment in our department between July 1992 and March 2011.
RESULTS: Mean age was 62.4 years. Clinical stages were: stage I (n=4, 8.9%); stage II (n=10, 22.2%); stage III (n=5, 11.1%); and stage IVa (n=26, 57.8%). Surgical resection was performed in all patients and 6 patients also received postoperative radiotherapy. Reconstructive surgery using free flaps was performed in 38 patients; postoperative complications occurred in 5 of these patients. The 3-year local control rate was 80%, and the 3-year over all survival rates for stage I, II, III, and IV disease were 100%, 80%, 40%, and 49.2%, respectively. Cause of death was the original disease in 23 cases and other diseases in 2 cases. The most common cause of death from the original disease was cervical lymph node metastasis.
CONCLUSION: The presence of cervical lymph node metastasis was a negative prognostic factor. Marginal mandibulectomy may be selected for patients without distinct bone-marrow infiltration.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Marginal mandibulectomy; Retromolar trigone; Retrospective analysis; Segmental mandibulectomy; Squamous cell carcinoma

Mesh:

Year:  2017        PMID: 28624429     DOI: 10.1016/j.anl.2017.05.011

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  3 in total

1.  Survival outcomes after treatment of cancer of the oral cavity (1985-2015).

Authors:  Daniella Karassawa Zanoni; Pablo H Montero; Jocelyn C Migliacci; Jatin P Shah; Richard J Wong; Ian Ganly; Snehal G Patel
Journal:  Oral Oncol       Date:  2019-02-15       Impact factor: 5.337

2.  Treatment Outcomes for Primary Retromolar Trigone Carcinoma: A Single Institution Experience.

Authors:  Uygar Levent Demir; Halide Öztürk Yanaşma
Journal:  Turk Arch Otorhinolaryngol       Date:  2020-06-01

3.  Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Oral Cavity Cancer in the Era of Modern Radiation Techniques.

Authors:  Tae Hyung Kim; In-Ho Cha; Eun Chang Choi; Hye Ryun Kim; Hyung Jun Kim; Se-Heon Kim; Ki Chang Keum; Chang Geol Lee
Journal:  Front Oncol       Date:  2021-03-12       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.